[
  {
    "ts": null,
    "headline": "UnitedHealth Q4 Earnings Beat on Strong Optum Rx, Offers 2026 Outlook",
    "summary": "UNH tops Q4 EPS estimates as Optum Rx drove growth, but profits plunged year over year, and management set a cautious 2026 outlook amid rising costs.",
    "url": "https://finnhub.io/api/news?id=214b3c3784d9a254a21a2818b8a65f7fef96a33998a2c666ea5b092ebff782e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769532720,
      "headline": "UnitedHealth Q4 Earnings Beat on Strong Optum Rx, Offers 2026 Outlook",
      "id": 138273993,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "UNH tops Q4 EPS estimates as Optum Rx drove growth, but profits plunged year over year, and management set a cautious 2026 outlook amid rising costs.",
      "url": "https://finnhub.io/api/news?id=214b3c3784d9a254a21a2818b8a65f7fef96a33998a2c666ea5b092ebff782e1"
    }
  },
  {
    "ts": null,
    "headline": "Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics",
    "summary": "Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.",
    "url": "https://finnhub.io/api/news?id=de1d4b8fbf5ed08fa088da68aecaf199977aa0203937e40d49c3a57b538d8f06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769523306,
      "headline": "Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics",
      "id": 138271213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.",
      "url": "https://finnhub.io/api/news?id=de1d4b8fbf5ed08fa088da68aecaf199977aa0203937e40d49c3a57b538d8f06"
    }
  },
  {
    "ts": null,
    "headline": "Dr. Peter Craig Farrell, Founder of ResMed, Inc., to Receive Prestigious 2026 Horatio Alger Award",
    "summary": "The Horatio Alger Association of Distinguished Americans, Inc., a nonprofit that honors leaders who have overcome adversity and supports young people in furthering their education, today announced that Dr. Peter Craig Farrell, Founder of ResMed, Inc., will receive the prestigious Horatio Alger Award and become a lifetime member of the organization. Farrell joins 10 other exceptional corporate, civic, and cultural leaders from across the country in the 2026 class of honorees. For the last 79 year",
    "url": "https://finnhub.io/api/news?id=db0ef32e463b426dc9415ed5421683172fe3ed4da23ab1cf5f5911e4d4a0256b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769518800,
      "headline": "Dr. Peter Craig Farrell, Founder of ResMed, Inc., to Receive Prestigious 2026 Horatio Alger Award",
      "id": 138270268,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "The Horatio Alger Association of Distinguished Americans, Inc., a nonprofit that honors leaders who have overcome adversity and supports young people in furthering their education, today announced that Dr. Peter Craig Farrell, Founder of ResMed, Inc., will receive the prestigious Horatio Alger Award and become a lifetime member of the organization. Farrell joins 10 other exceptional corporate, civic, and cultural leaders from across the country in the 2026 class of honorees. For the last 79 year",
      "url": "https://finnhub.io/api/news?id=db0ef32e463b426dc9415ed5421683172fe3ed4da23ab1cf5f5911e4d4a0256b"
    }
  },
  {
    "ts": null,
    "headline": "Resmed's Q2 Earnings on Deck: What's in Store for the Stock?",
    "summary": "RMD is set to report Q2 results on Jan. 29, with revenues likely to jump 8.3% and EPS 10.3% as masks, devices and software drive growth.",
    "url": "https://finnhub.io/api/news?id=cf2eb56885044b07d316f5469ebe8ef56be1e5c1491d040fc44deb1ea9fbf4bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769518440,
      "headline": "Resmed's Q2 Earnings on Deck: What's in Store for the Stock?",
      "id": 138271191,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "RMD is set to report Q2 results on Jan. 29, with revenues likely to jump 8.3% and EPS 10.3% as masks, devices and software drive growth.",
      "url": "https://finnhub.io/api/news?id=cf2eb56885044b07d316f5469ebe8ef56be1e5c1491d040fc44deb1ea9fbf4bf"
    }
  }
]